Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate.

Flavanols from chocolate appear to increase nitric oxide bioavailability, protect vascular endothelium, and decrease cardiovascular disease (CVD) risk factors. We sought to test the effect of flavanol-rich dark chocolate (FRDC) on endothelial function, insulin sensitivity, beta-cell function, and blood pressure (BP) in hypertensive patients with impaired glucose tolerance (IGT). After a run-in phase, 19 hypertensives with IGT (11 males, 8 females; 44.8 +/- 8.0 y) were randomized to receive isocalorically either FRDC or flavanol-free white chocolate (FFWC) at 100 g/d for 15 d. After a wash-out period, patients were switched to the other treatment. Clinical and 24-h ambulatory BP was determined by sphygmometry and oscillometry, respectively, flow-mediated dilation (FMD), oral glucose tolerance test, serum cholesterol and C-reactive protein, and plasma homocysteine were evaluated after each treatment phase. FRDC but not FFWC ingestion decreased insulin resistance (homeostasis model assessment of insulin resistance; P < 0.0001) and increased insulin sensitivity (quantitative insulin sensitivity check index, insulin sensitivity index (ISI), ISI(0); P < 0.05) and beta-cell function (corrected insulin response CIR(120); P = 0.035). Systolic (S) and diastolic (D) BP decreased (P < 0.0001) after FRDC (SBP, -3.82 +/- 2.40 mm Hg; DBP, -3.92 +/- 1.98 mm Hg; 24-h SBP, -4.52 +/- 3.94 mm Hg; 24-h DBP, -4.17 +/- 3.29 mm Hg) but not after FFWC. Further, FRDC increased FMD (P < 0.0001) and decreased total cholesterol (-6.5%; P < 0.0001), and LDL cholesterol (-7.5%; P < 0.0001). Changes in insulin sensitivity (Delta ISI - Delta FMD: r = 0.510, P = 0.001; Delta QUICKI - Delta FMD: r = 0.502, P = 0.001) and beta-cell function (Delta CIR(120) - Delta FMD: r = 0.400, P = 0.012) were directly correlated with increases in FMD and inversely correlated with decreases in BP (Delta ISI - Delta 24-h SBP: r = -0.368, P = 0.022; Delta ISI - Delta 24-h DBP r = -0.384, P = 0.017). Thus, FRDC ameliorated insulin sensitivity and beta-cell function, decreased BP, and increased FMD in IGT hypertensive patients. These findings suggest flavanol-rich, low-energy cocoa food products may have a positive impact on CVD risk factors.

[1]  P. Zimmet,et al.  Diagnosis and classification of diabetes mellitus , 2002 .

[2]  C. Lehmann,et al.  Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. , 2007, JAMA.

[3]  R. Schmieder,et al.  Guidelines for management of arterial hypertension , 2007 .

[4]  N. Hollenberg,et al.  Aging and vascular responses to flavanol-rich cocoa , 2006, Journal of hypertension.

[5]  M. McCullough,et al.  Hypertension, the Kuna, and the Epidemiology of Flavanols , 2006, Journal of cardiovascular pharmacology.

[6]  M. Quon,et al.  Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms , 2006, Circulation.

[7]  E. Feskens,et al.  Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. , 2006, Archives of internal medicine.

[8]  N. Hollenberg,et al.  (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Fraga,et al.  Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. , 2006, Journal of agricultural and food chemistry.

[10]  E. Ding,et al.  Nutrition & Metabolism BioMed Central Review Chocolate and Prevention of Cardiovascular Disease: A Systematic Review , 2005 .

[11]  H. Sies,et al.  Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. , 2005, Journal of the American College of Cardiology.

[12]  JoAnn E Manson,et al.  Associations of Dietary Flavonoids with Risk of Type 2 Diabetes, and Markers of Insulin Resistance and Systemic Inflammation in Women: A Prospective Study and Cross-Sectional Analysis , 2005, Journal of the American College of Nutrition.

[13]  J. Blumberg,et al.  Cocoa Reduces Blood Pressure and Insulin Resistance and Improves Endothelium-Dependent Vasodilation in Hypertensives , 2005, Hypertension.

[14]  C. Kelly.  Effects of theobromine should be considered in future studies. , 2005, The American journal of clinical nutrition.

[15]  M. Hamid,et al.  The effect of Malaysian cocoa extract on glucose levels and lipid profiles in diabetic rats. , 2005, Journal of ethnopharmacology.

[16]  D. Cucinotta,et al.  Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women , 2005, Menopause.

[17]  S. Necozione,et al.  Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. , 2005, The American journal of clinical nutrition.

[18]  C. Fraga,et al.  Regular Consumption of a Flavanol-rich Chocolate can Improve Oxidant Stress in Young Soccer Players , 2005, Clinical & developmental immunology.

[19]  Masafumi Matsuda,et al.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. , 2005, The Journal of clinical endocrinology and metabolism.

[20]  M. Mccarty,et al.  Potential utility of natural polyphenols for reversing fat-induced insulin resistance. , 2005, Medical hypotheses.

[21]  D. Schuster,et al.  Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. , 2004, Diabetes care.

[22]  S. Paul,et al.  Flavonoid-Rich Dark Chocolate Improves Endothelial Function and Increases Plasma Epicatechin Concentrations in Healthy Adults , 2004, Journal of the American College of Nutrition.

[23]  S. Priori,et al.  2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension , 2003, Heart Drug.

[24]  N. Hollenberg,et al.  Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans , 2003, Journal of hypertension.

[25]  A. Shore,et al.  Insulin and lysophosphatidylcholine synergistically stimulate NO‐dependent cGMP production in human endothelial cells , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[26]  H. Sies,et al.  Vascular effects of cocoa rich in flavan-3-ols. , 2003, JAMA.

[27]  W. Klaus,et al.  Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. , 2003, JAMA.

[28]  D. Ryan.  Diet and exercise in the prevention of diabetes. , 2003, International journal of clinical practice. Supplement.

[29]  M. Hanefeld,et al.  In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance. , 2002, Diabetes.

[30]  R. Hanson,et al.  Family and genetic studies of indices of insulin sensitivity and insulin secretion in Pima Indians † ‡ , 2001, Diabetes/metabolism research and reviews.

[31]  K. Nakao,et al.  Insulin resistance and endothelial dysfunction in smokers: effects of vitamin C. , 2000, American journal of physiology. Heart and circulatory physiology.

[32]  C. Kappagoda,et al.  Effects of cocoa extracts on endothelium-dependent relaxation. , 2000, The Journal of nutrition.

[33]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[34]  K. Kugiyama,et al.  Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. , 2000, Journal of the American College of Cardiology.

[35]  C. Bogardus,et al.  Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. , 2000, American journal of epidemiology.

[36]  E. Feskens,et al.  Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.

[37]  R. Samson,et al.  Hemodynamic and electrophysiologic effects of acute chocolate ingestion in young adults. , 1999, The American journal of cardiology.

[38]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[39]  A. Busjahn,et al.  Endothelial cell dysfunction and arterial wall hypertrophy are associated with disturbed carbohydrate metabolism in patients at risk for cardiovascular disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[40]  L Bravo,et al.  Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. , 2009, Nutrition reviews.

[41]  M. Velussi,et al.  Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. , 1997, Journal of hepatology.

[42]  A. Baron,et al.  Effect of perfusion rate on the time course of insulin-mediated skeletal muscle glucose uptake. , 1996, The American journal of physiology.

[43]  W. Reitsma,et al.  Glucose Tolerance and Insulin Release, A Mathematical Approach: I. Assay of the Beta-cell Response After Oral Glucose Loading , 1976, Diabetes.

[44]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.